Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01835691 · ClinicalTrials.gov registry record · NA
Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease
A NA study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT01835691: Completed NA study, sponsored by University of Kansas Medical Center.
NCT01835691 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01835691, a NA study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study is to research two questions. First, is vitamin D3 more effective than vitamin D2 in raising 25-hydroxyvitamin D \[25(OH)D\] levels in chronic kidney disease (CKD) patients? And secondly, what are the differential effects of vitamin D2 and vitamin D3 on other mineral metabolism parameters?
Interventions
- DIETARY_SUPPLEMENT Vitamin D3 (cholecalciferol)
- DIETARY_SUPPLEMENT Vitamin D2 (ergocalciferol)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT01835691 record still lists
NCT01835691 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Vitamin D3 (cholecalciferol) is the first listed.
NCT01835691 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01835691 about?
NCT01835691 is a clinical study titled "Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease". This study is to research two questions. First, is vitamin D3 more effective than vitamin D2 in raising 25-hydroxyvitamin D \[25(OH)D\] levels in chronic kidney disease (CKD) patients? And secondly, what are the differential effects of vitamin D2 and vitamin D3 on other mineral metabolism parameters...
What is the current status of trial NCT01835691?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2011-10. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01835691?
The interventions under investigation include: Vitamin D3 (cholecalciferol) (DIETARY_SUPPLEMENT), Vitamin D2 (ergocalciferol) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01835691?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01835691's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia